Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...

Eli Lilly and Company's correction may be coming to an end as the actual demand for its drugs seems to be holding well. Learn more about LLY stock here.

We recently published a list of the 12 Best Stocks to Buy in 2025 for Beginners. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best ...

Metsera is aiming to put its weight loss drug MET-097i, which boasts of a longer half-life, through Phase III trials.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and ...

Eli Lilly and Company ( NYSE:LLY – Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.18 earnings per share (EPS) for the quarter, missing ...

Weight loss treatments Mounjaro and Zepbound are the primary growth engines for Eli Lilly right now, but the company has another enormous opportunity that's getting very little attention.

There are many ways to diversify beyond the S&P 500. One is to hold shares of the Invesco S&P 500 Equal Weight ETF RSP. Another, according to Davis, is to take an even broader index-fund approach. One ...

When investors are paying such high price tags for a stock, expectations are high, and any kind of miss can result in a steep ...

Artificial intelligence (AI) stocks have been some of the best investments to be holding in recent years. Chipmaker Nvidia ...

Eli Lilly (NYSE: LLY) doesn’t really need much of an introduction. It has become a household name due to its obesity and ...

The Dow Jones rallied on the stock market today. A Donald Trump stock dived while Cathie Wood snapped up a plunging AI stock.